Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)

Historical Holders from Q1 2019 to Q3 2025

Symbol
INMB on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
28M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
4.65M
Holdings value
$9.63M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
72
Number of buys
35
Number of sells
-45
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HIGHBRIDGE CAPITAL MANAGEMENT LLC 5.2% $3.36M 1.45M Highbridge Capital Management, LLC 30 Jun 2025
CVI Investments, Inc. 4.9% -10% $3.23M -$240K 1.4M -6.91% CVI Investments, Inc. 30 Jun 2025
Praetorian PR LLC 3.4% -54.3% $2.13M -$1.7M 921K -44.4% Kupperman Harris 30 Jun 2025

Institutional Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 4.65M $9.63M -$1.93M $2.07 72
2025 Q2 5.62M $12.7M -$10M $2.31 78
2025 Q1 6.16M $48.1M -$164K $7.81 81
2024 Q4 6.32M $29.5M +$2.16M $4.67 72
2024 Q3 5.35M $28.8M +$6.03M $5.39 65
2024 Q2 4.57M $40.3M +$15.4M $8.82 56
2024 Q1 2.74M $32.2M +$5.31M $11.75 50
2023 Q4 2.29M $25.8M +$1.85M $11.26 47
2023 Q3 2.13M $14.5M -$5.89M $6.77 36
2023 Q2 2.19M $24.9M +$8.53M $9.08 32
2023 Q1 1.8M $11.7M +$1.1M $6.46 33
2022 Q4 1.65M $10.4M -$728K $6.34 32
2022 Q3 1.91M $11.9M -$744K $6.20 32
2022 Q2 2.01M $17.6M -$2.41M $8.84 34
2022 Q1 2.29M $19.3M -$2.11M $8.42 32
2021 Q4 2.48M $25.3M +$4.76M $10.20 42
2021 Q3 1.94M $37.7M +$4.89M $19.42 40
2021 Q2 1.71M $30.1M +$8.04M $17.57 39
2021 Q1 1.31M $15.5M +$5.44M $11.88 32
2020 Q4 793K $13.7M +$1.19M $17.21 25
2020 Q3 993K $10.3M +$6.46M $10.30 27
2020 Q2 359K $1.88M +$105K $5.17 11
2020 Q1 342K $1.14M +$201K $3.32 9
2019 Q4 282K $1.64M +$40.4K $5.80 9
2019 Q3 275K $1.62M +$1.39M $5.90 9
2019 Q2 38.5K $373K -$44K $9.72 7
2019 Q1 45.1K $352K +$352K $7.44 5